ORBIMED ADVISORS LLC
Top Portfolio Positions
106 positions ·
$5,343,151,020 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
125,000,000 | $562,500,000 | 10.53% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
15,518,492 | $488,832,498 | 9.15% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
7,959,538 | $312,013,889 | 5.84% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
82,010,995 | $303,440,681 | 5.68% | |
| MDXH |
MDxHealth SA
Healthcare
|
124,306,000 | $285,903,800 | 5.35% | |
| LLY |
ELI LILLY & Co
Healthcare
|
236,800 | $217,801,536 | 4.08% | |
| BSX |
Boston Scientific Corp
Healthcare
|
2,382,100 | $149,476,775 | 2.80% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
3,530,702 | $141,545,843 | 2.65% | |
| AZN |
Astrazeneca PLC
Healthcare
|
670,200 | $132,176,844 | 2.47% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,637,887 | $108,590,926 | 2.03% |
Portfolio Trend
Holdings in CRVS
Shares Held
Position Value (USD)
25 of 25 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,824,037 | 7,165,006 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $55,170,546 | 7,165,006 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,806,094 | 7,165,006 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,660,024 | 7,165,006 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,080,819 | 6,943,654 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,148,548 | 6,943,654 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $36,662,493 | 6,943,654 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,637,450 | 6,943,654 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,359,704 | 6,943,654 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,220,831 | 6,943,654 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,137,734 | 6,943,654 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,900,967 | 6,943,654 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,318,725 | 6,943,654 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,902,105 | 6,943,654 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,686,852 | 6,943,654 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,874,217 | 6,943,654 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,387,592 | 6,943,654 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,734,206 | 6,943,654 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,607,285 | 6,943,654 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,502,305 | 8,053,298 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,804,157 | 8,053,298 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,092,599 | 6,767,584 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $27,138,011 | 6,767,584 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $18,407,828 | 6,767,584 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $14,279,602 | 6,767,584 | Shares | Sole | 2020-05-15 | |
| No quarters match your search. | ||||||